FeesSafety
Pluang+

Enerflex appoints Christine Morris as new CFO starting January 2027, succeeding Preet Dhindsa.

Market News
19 Nov 2026, 02:00 WIB
GlobeNewsWire
View Source
Bullish
Enerflex appoints Christine Morris as new CFO starting January 2027, succeeding Preet Dhindsa.

Enerflex Ltd. announced that Christine Morris will become the new Senior Vice President and Chief Financial Officer effective January 1, 2027, replacing Preet S. Dhindsa who will step down on December 31, 2026. Morris brings over 30 years of global financial leadership experience in energy and industrial sectors, expected to support Enerflex's growth and shareholder value goals. The company highlighted her expertise in financial strategy and business transformation as key to advancing their strategic priorities, including profitability and cash flow improvement. This leadership change comes as Enerflex continues to focus on growth and sustainability in the natural gas sector.

Enerflex Ltd.'s CFO transition is noted alongside Pluang's snapshot of the Energy sector as of Nov 19, 2026 03:41 WIB: out of 79 priced US energy stocks, 13 rose and 66 fell. Key movers include Suncor Energy Inc. (SU) at USD 65.00 with a 1-day change of -4.72% and a typical hold time on Pluang of 59 days, Crescent Energy Company Class A (CRGY) at USD 10.83 down 4.67% but with 100% buy order activity, and Phillips 66 (PSX) priced at USD 245.02 down 4.64% with 100% buy order activity and a typical hold time of 63 days.

More News

Micron's strong growth and rising stock price hint at a possible future stock split.

Micron's strong growth and rising stock price hint at a possible future stock split.

Micron Technology is showing strong financial growth, driven by its crucial role in AI infrastructure and multiyear deals with key tech companies. The company recently beat revenue expectations with a 379% year-over-year increase and projects even be...

Company Fundamentals
Bullish
1 hour ago
FDA approves Livsayis™, first siRNA therapy for generalized myasthenia gravis, offering new treatment option.

FDA approves Livsayis™, first siRNA therapy for generalized myasthenia gravis, offering new treatment option.

The FDA has approved Livsayis™ (cemdisiran), the first and only siRNA therapy for adults with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor antibody-positive. This subcutaneous treatment, administered four times a year, targ...

Market News
Bullish
1 hour ago
Elauwit reports 66% growth in monthly recurring revenue to $539K, cutting expenses and expanding managed Wi-Fi networks.

Elauwit reports 66% growth in monthly recurring revenue to $539K, cutting expenses and expanding managed Wi-Fi networks.

Elauwit announced a 66% year-over-year increase in monthly recurring revenue to $539,000 by the end of Q3 2026, driven by long-term contracts for managed Wi-Fi in apartment communities. The company also reduced operating expenses by 19% sequentially ...

Company Fundamentals
Bullish
1 hour ago
Montauk Renewables delays capital spending, seeks credit amendments amid operational challenges.

Montauk Renewables delays capital spending, seeks credit amendments amid operational challenges.

Montauk Renewables deferred up to $120 million in capital spending and is negotiating credit facility amendments due to operational delays at its North Carolina swine waste project. These delays have created short-term risks for debt covenants, requi...

Company Fundamentals
Neutral
1 hour ago
Palantir's revenue soars past $2B, outpacing UiPath's slower, seasonal growth in AI software sales.

Palantir's revenue soars past $2B, outpacing UiPath's slower, seasonal growth in AI software sales.

Palantir Technologies has shown rapid quarter-over-quarter revenue growth, reaching $2.3 billion in Q3 2026, driven by strong commercial adoption of its AI platform and expansion beyond government contracts. In contrast, UiPath's revenue growth is mo...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App